Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT00589420
Title Sorafenib and Docetaxel in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Previous Hormone Therapy
Recruitment Completed
Gender male
Phase Phase II
Variant Requirements No
Sponsors University of Pennsylvania

prostate adenocarcinoma


Docetaxel + Sorafenib

Age Groups: adult
Covered Countries USA

No variant requirements are available.